Stockscreener 앱 받기
131.64
1.26%
1.64
시간 외 거래:
132.70
1.06
+0.81%
전일 마감가:
$130.00
열려 있는:
$129.43
하루 거래량:
678.85K
Relative Volume:
0.93
시가총액:
$7.15B
수익:
$633.51M
순이익/손실:
$-8.10M
주가수익비율:
-424.65
EPS:
-0.31
순현금흐름:
$131.26M
1주 성능:
+3.44%
1개월 성능:
-5.98%
6개월 성능:
-11.78%
1년 성능:
-16.23%
1일 변동 폭
$125.05
$132.41
1주일 범위
$123.97
$135.81
52주 변동 폭
$102.97
$182.52
Repligen Corp Stock (RGEN) Company Profile
명칭
Repligen Corp
전화
(781) 449-9560
주소
41 SEYON STREET, WALTHAM, MA
RGEN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RGEN
Repligen Corp
|
131.64 | 7.15B | 633.51M | -8.10M | 131.26M | -0.31 |
|
ISRG
Intuitive Surgical Inc
|
468.32 | 175.60B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
196.61 | 59.07B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
91.38 | 44.80B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
210.87 | 31.51B | 4.93B | 1.25B | 1.38B | 8.47 |
|
COO
The Cooper Companies, Inc.
|
78.70 | 15.83B | 3.90B | 392.30M | 288.10M | 1.95 |
Repligen Corp Stock (RGEN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-18 | 개시 | Evercore ISI | In-line |
| 2025-02-10 | 개시 | TD Cowen | Buy |
| 2024-12-17 | 개시 | Canaccord Genuity | Hold |
| 2024-11-14 | 개시 | Wolfe Research | Peer Perform |
| 2024-08-28 | 개시 | Wells Fargo | Overweight |
| 2024-06-26 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2024-06-18 | 개시 | Guggenheim | Neutral |
| 2023-12-04 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2023-07-20 | 개시 | Wells Fargo | Overweight |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-03-28 | 개시 | The Benchmark Company | Buy |
| 2022-12-14 | 개시 | Deutsche Bank | Hold |
| 2022-12-07 | 개시 | RBC Capital Mkts | Sector Perform |
| 2022-07-20 | 개시 | UBS | Buy |
| 2021-10-14 | 개시 | Exane BNP Paribas | Outperform |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-08-24 | 재확인 | H.C. Wainwright | Buy |
| 2020-06-30 | 재확인 | H.C. Wainwright | Buy |
| 2020-05-07 | 재확인 | H.C. Wainwright | Buy |
| 2020-03-23 | 재확인 | H.C. Wainwright | Buy |
| 2019-11-15 | 개시 | Stifel | Buy |
| 2019-11-01 | 업그레이드 | First Analysis Sec | Outperform → Strong Buy |
| 2019-10-15 | 개시 | SVB Leerink | Outperform |
| 2019-08-28 | 재확인 | First Analysis Sec | Outperform |
| 2019-08-23 | 재개 | Stephens | Overweight |
| 2019-07-22 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2018-12-17 | 업그레이드 | CL King | Neutral → Buy |
| 2018-11-12 | 다운그레이드 | CL King | Buy → Neutral |
| 2018-09-26 | 개시 | H.C. Wainwright | Neutral |
| 2017-12-08 | 개시 | Citigroup | Buy |
| 2017-12-05 | 개시 | JP Morgan | Overweight |
| 2017-11-13 | 개시 | CL King | Buy |
| 2017-10-02 | 업그레이드 | First Analysis Sec | Equal-Weight → Overweight |
| 2017-07-21 | 개시 | William Blair | Outperform |
| 2017-02-13 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
모두보기
Repligen Corp 주식(RGEN)의 최신 뉴스
Repligen (NASDAQ:RGEN) Cut to “Sell” at StockNews.com - Defense World
Repligen to Report First Quarter 2025 Financial Results - Yahoo Finance
Repligen Corp (RGEN) Shares Up 4.7% on Apr 11 - GuruFocus
Hollow Fiber Filtration Market Future Business Opportunities - openPR.com
Repligen’s 39% decline validates InvestingPro’s bearish Fair Value call By Investing.com - Investing.com India
Repligen's 39% decline validates InvestingPro's bearish Fair Value call By Investing.com - Investing.com
Repligen (RGEN): Buy, Sell, Or Hold Post Q4 Earnings? - Barchart.com
Repligen (RGEN): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance
StockNews.com Upgrades Repligen (NASDAQ:RGEN) to "Hold" - MarketBeat
Analysts’ Revisions Show Improving Sentiment For Repligen Corp (NASDAQ: RGEN) - stocksregister.com
Repligen Appoints Jacob Johnson As Vice President Investor Relations - Yahoo Finance
Repligen (RGEN) Moves 3.7% Higher: Will This Strength Last? - Yahoo Finance
Norges Bank Takes $24.03 Million Position in Repligen Co. (NASDAQ:RGEN) - Defense World
Repligen (NASDAQ:RGEN) Upgraded at StockNews.com - The AM Reporter
Repligen (NASDAQ:RGEN) Raised to Hold at StockNews.com - Defense World
Repligen stock touches 52-week low at $113.24 amid market shifts By Investing.com - Investing.com South Africa
Repligen stock touches 52-week low at $113.24 amid market shifts - Investing.com
Groupama Asset Managment Purchases 400,680 Shares of Repligen Co. (NASDAQ:RGEN) - MarketBeat
Corient Private Wealth LLC Trims Stake in Repligen Co. (NASDAQ:RGEN) - Defense World
HighTower Advisors LLC Sells 180 Shares of Repligen Co. (NASDAQ:RGEN) - Defense World
Repligen Corp (NASDAQ: RGEN): Getting A Free Pass? - Stocks Register
Repligen Co. (NASDAQ:RGEN) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Global Hollow Fiber Filtration Market to Witness Massive Growth - openPR.com
Envestnet Portfolio Solutions Inc. Lowers Holdings in Repligen Co. (NASDAQ:RGEN) - The AM Reporter
Is Repligen Corporation (RGEN) the Top Stock to Buy According to 12 West Capital Management? - Insider Monkey
Insider Buying: Margaret Pax Acquires Shares of Repligen Corp (R - GuruFocus
Repligen Corp (RGEN) Shares Gap Down to $139.34 on Mar 21 - GuruFocus.com
PNC Financial Services Group Inc. Sells 262 Shares of Repligen Co. (NASDAQ:RGEN) - Defense World
Repligen Corp director Hunt Anthony sells $4.08 million in stock By Investing.com - Investing.com South Africa
Repligen Corp director Hunt Anthony sells $4.08 million in stock - Investing.com
Repligen’s SWOT analysis: bioprocessing leader’s stock faces growth and valuation challenges - Investing.com
Repligen (NASDAQ:RGEN) Coverage Initiated by Analysts at Evercore ISI - Defense World
Proficio Capital Partners LLC Makes New Investment in Repligen Co. (NASDAQ:RGEN) - Defense World
Repligen Co. (NASDAQ:RGEN) Shares Sold by Victory Capital Management Inc. - Defense World
Repligen director Pax Margaret acquires $37,672 in common stock By Investing.com - Investing.com Australia
Repligen director Pax Margaret acquires $37,672 in common stock - Investing.com
REPLIGEN Director Margaret Pax Acquires 250 Shares - TradingView
Evercore ISI sets Repligen stock In Line with $155 price target - Investing.com
Demystifying Repligen: Insights From 6 Analyst Reviews - Benzinga
Repligen initiated with an In Line at Evercore ISI - TipRanks
Repligen Corp (RGEN) Shares Up 5.72% on Mar 17 - GuruFocus.com
Repligen Corp (RGEN) Shares Up 5.72% on Mar 15 - GuruFocus.com
REPLIGEN CORP SEC 10-K Report - TradingView
Charles Schwab Investment Management Inc. Grows Position in Repligen Co. (NASDAQ:RGEN) - Defense World
William Blair Brokers Reduce Earnings Estimates for Repligen - Defense World
A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack - The Globe and Mail
Oppenheimer & Co. Inc. Purchases New Shares in Repligen Co. (NASDAQ:RGEN) - Defense World
Repligen Corporation’s Acquisition of Bioprocessing PAT Device Portfolio from 908 Devices - Global Legal Chronicle
US Bancorp DE Raises Position in Repligen Co. (NASDAQ:RGEN) - Defense World
Repligen buying 908 Devices’ Bioprocess Analytics portfolio - BioWorld Online
Sanctuary Advisors LLC Sells 268 Shares of Repligen Co. (NASDAQ:RGEN) - Defense World
Repligen Corp (RGEN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.50%
0.47%
자본화:
|
볼륨(24시간):